Keywords
Last Name
Institution

Kevin M Gray

TitleAssistant Provost for Research Advancement
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
Suit 190
125 Doughty St.
Phone843-792-6330
Fax843-792-3982
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Gray maintains active clinical practice and conducts National Institutes of Health sponsored clinical research on substance use disorders in adolescents and adults, with particular emphasis on treatment development for cannabis and tobacco use disorders in youth. With a multidisciplinary group of collaborators at MUSC, Dr. Gray investigates biobehavioral mechanisms underlying substance use disorders, and works to apply these findings to real world clinical practice.

    Collapse keywords
    adolescent, cannabis, marijuana, tobacco, treatment, Drug Studies, Psychiatry, Mental Health, ADD/ADHD, Pediatrics, Smoking, Substance Use

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Karoly HC, Schacht JP, Jacobus J, Meredith LR, Taylor CT, Tapert SF, Gray KM, Squeglia LM. Preliminary evidence that computerized approach avoidance training is not associated with changes in fMRI cannabis cue reactivity in non-treatment-seeking adolescent cannabis users. Drug Alcohol Depend. 2019 Jul 01; 200:145-152. PMID: 31132681.
      View in: PubMed
    2. Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM. Pharmacological Treatment of Youth Substance Use Disorders. J Child Adolesc Psychopharmacol. 2019 Apr 22. PMID: 31009234.
      View in: PubMed
    3. Montgomery L, McClure EA, Tomko RL, Sonne SC, Winhusen T, Terry GE, Grossman JT, Gray KM. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 May 01; 198:105-111. PMID: 30901744.
      View in: PubMed
    4. Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM. Methods to reduce the incidence of false negative trial results in substance use treatment research. Curr Opin Psychol. 2019 Jan 28; 30:35-41. PMID: 30798020.
      View in: PubMed
    5. Tomko RL, Saladin ME, Baker NL, McClure EA, Carpenter MJ, Ramakrishnan VR, Heckman BW, Wray JM, Foster KT, Tiffany ST, Metts CL, Gray KM. Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res. 2018 Oct 26. PMID: 30371887.
      View in: PubMed
    6. Tomko RL, Gilmore AK, Gray KM. Corrigendum to The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine Addictive Behaviors 85 (2018) 26-30. Addict Behav. 2019 Feb; 89:263. PMID: 30268706.
      View in: PubMed
    7. Karoly HC, Schacht JP, Meredith LR, Jacobus J, Tapert SF, Gray KM, Squeglia LM. Investigating a novel fMRI cannabis cue reactivity task in youth. Addict Behav. 2019 Feb; 89:20-28. PMID: 30243035.
      View in: PubMed
    8. McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66. PMID: 30218864.
      View in: PubMed
    9. Sahlem GL, Tomko RL, Sherman BJ, Gray KM, McRae-Clark AL. Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. Int Rev Psychiatry. 2018 06; 30(3):216-225. PMID: 29956576.
      View in: PubMed
    10. Tomko RL, Jones JL, Gilmore AK, Brady KT, Back SE, Gray KM. N-acetylcysteine: A potential treatment for substance use disorders. Curr Psychiatr. 2018 06; 17(6):30-36, 41-42, 55. PMID: 30016376.
      View in: PubMed
    11. Tomko RL, Gilmore AK, Gray KM. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Addict Behav. 2018 Oct; 85:26-30. PMID: 29803870.
      View in: PubMed
    12. McClure EA, Tomko RL, Carpenter MJ, Treiber FA, Gray KM. Acceptability and compliance with a remote monitoring system to track smoking and abstinence among young smokers. Am J Drug Alcohol Abuse. 2018; 44(5):561-570. PMID: 29737885.
      View in: PubMed
    13. Baker NL, Gray KM, Sherman BJ, Morella K, Sahlem GL, Wagner AM, McRae-Clark AL. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. Drug Alcohol Depend. 2018 06 01; 187:270-277. PMID: 29698894.
      View in: PubMed
    14. Jacobus J, Taylor CT, Gray KM, Meredith LR, Porter AM, Li I, Castro N, Squeglia LM. A multi-site proof-of-concept investigation of computerized approach-avoidance training in adolescent cannabis users. Drug Alcohol Depend. 2018 06 01; 187:195-204. PMID: 29679914.
      View in: PubMed
    15. Bagot KS, Matthews SA, Mason M, Squeglia LM, Fowler J, Gray K, Herting M, May A, Colrain I, Godino J, Tapert S, Brown S, Patrick K. Current, future and potential use of mobile and wearable technologies and social media data in the ABCD study to increase understanding of contributors to child health. Dev Cogn Neurosci. 2018 08; 32:121-129. PMID: 29636283.
      View in: PubMed
    16. Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA. Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. Am J Drug Alcohol Abuse. 2019; 45(1):26-41. PMID: 29513609.
      View in: PubMed
    17. Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug Alcohol Depend. 2018 04 01; 185:17-22. PMID: 29413434.
      View in: PubMed
    18. Gray KM. THC potency needs to be tracked. Am J Addict. 2018 Jan; 27(1):46. PMID: 29283485.
      View in: PubMed
    19. Meier E, Burris JL, Wahlquist A, Garrett-Mayer E, Gray KM, Alberg AJ, Cummings KM, Carpenter MJ. Perceptions of Snus Among US Adult Smokers Given Free Product. Nicotine Tob Res. 2017 Dec 13; 20(1):22-29. PMID: 28034999.
      View in: PubMed
    20. Carpenter MJ, Heckman BW, Wahlquist AE, Wagener TL, Goniewicz ML, Gray KM, Froeliger B, Cummings KM. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803. PMID: 29127080.
      View in: PubMed
    21. Tomko RL, Baker NL, McClure EA, Sonne SC, McRae-Clark AL, Sherman BJ, Gray KM. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7. PMID: 29112827.
      View in: PubMed
    22. Rice LJ, Emerson E, Gray KM, Howlin P, Tonge BJ, Warner GL, Einfeld SL. Concurrence of the strengths and difficulties questionnaire and developmental behaviour checklist among children with an intellectual disability. J Intellect Disabil Res. 2018 Feb; 62(2):150-155. PMID: 28980362.
      View in: PubMed
    23. Hser YI, Mooney LJ, Huang D, Zhu Y, Tomko RL, McClure E, Chou CP, Gray KM. Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat. 2017 10; 81:53-58. PMID: 28847455.
      View in: PubMed
    24. Gray KM, Squeglia LM. Research Review: What have we learned about adolescent substance use? J Child Psychol Psychiatry. 2018 06; 59(6):618-627. PMID: 28714184.
      View in: PubMed
    25. Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257. PMID: 28623823.
      View in: PubMed
    26. McClure EA, King JS, Wahle A, Matthews AG, Sonne SC, Lofwall MR, McRae-Clark AL, Ghitza UE, Martinez M, Cloud K, Virk HS, Gray KM. Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20. PMID: 28511033.
      View in: PubMed
    27. Froeliger B, McConnell PA, Bell S, Sweitzer M, Kozink RV, Eichberg C, Hallyburton M, Kaiser N, Gray KM, McClernon FJ. Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability. JAMA Psychiatry. 2017 04 01; 74(4):379-386. PMID: 28249070.
      View in: PubMed
    28. Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144. PMID: 28152236.
      View in: PubMed
    29. Adisetiyo V, Gray KM. Neuroimaging the neural correlates of increased risk for substance use disorders in attention-deficit/hyperactivity disorder-A systematic review. Am J Addict. 2017 Mar; 26(2):99-111. PMID: 28106934.
      View in: PubMed
    30. Tomko RL, Saladin ME, McClure EA, Squeglia LM, Carpenter MJ, Tiffany ST, Baker NL, Gray KM. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology (Berl). 2017 Feb; 234(3):427-435. PMID: 27838746.
      View in: PubMed
    31. Back SE, McCauley JL, Korte KJ, Gros DF, Leavitt V, Gray KM, Hamner MB, DeSantis SM, Malcolm R, Brady KT, Kalivas PW. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446. PMID: 27736051.
      View in: PubMed
    32. W Adams Z, McClure EA, Gray KM, Danielson CK, Treiber FA, Ruggiero KJ. Mobile devices for the remote acquisition of physiological and behavioral biomarkers in psychiatric clinical research. J Psychiatr Res. 2017 02; 85:1-14. PMID: 27814455.
      View in: PubMed
    33. Keenan BM, Newman LK, Gray KM, Rinehart NJ. Parents of Children with ASD Experience More Psychological Distress, Parenting Stress, and Attachment-Related Anxiety. J Autism Dev Disord. 2016 Sep; 46(9):2979-91. PMID: 27312716.
      View in: PubMed
    34. Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict Behav. 2016 12; 63:172-7. PMID: 27521979.
      View in: PubMed
    35. Tomko RL, Bountress KE, Gray KM. Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug Alcohol Depend. 2016 Oct 01; 167:1-7. PMID: 27515725.
      View in: PubMed
    36. Burris JL, Wahlquist AE, Alberg AJ, Cummings KM, Gray KM, Garrett-Mayer E, Carpenter MJ. A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus. Addict Behav. 2016 12; 63:82-8. PMID: 27450153.
      View in: PubMed
    37. Dean OM, Gray KM, Villagonzalo KA, Dodd S, Mohebbi M, Vick T, Tonge BJ, Berk M. A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder. Aust N Z J Psychiatry. 2017 Mar; 51(3):241-249. PMID: 27316706.
      View in: PubMed
    38. Freeman NC, Gray KM, Taffe JR, Cornish KM. A cross-syndrome evaluation of a new attention rating scale: The Scale of Attention in Intellectual Disability. Res Dev Disabil. 2016 Oct; 57:18-28. PMID: 27348856.
      View in: PubMed
    39. Karch DL, Gray KM, Shi J, Hall HI. HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013. Open AIDS J. 2016; 10:127-35. PMID: 27386014.
      View in: PubMed
    40. Squeglia LM, Gray KM. Alcohol and Drug Use and the Developing Brain. Curr Psychiatry Rep. 2016 May; 18(5):46. PMID: 26984684.
      View in: PubMed
    41. Hammond CJ, Gray KM. Pharmacotherapy for Substance Use Disorders in Youths. J Child Adolesc Subst Abuse. 2016; 25(4):292-316. PMID: 28082828.
      View in: PubMed
    42. Carpenter MJ, Wahlquist AE, Burris JL, Gray KM, Garrett-Mayer E, Cummings KM, Alberg AJ. Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers. Tob Control. 2017 03; 26(2):202-209. PMID: 27071730.
      View in: PubMed
    43. Foster KT, Li N, McClure EA, Sonne SC, Gray KM. Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22. PMID: 27211992.
      View in: PubMed
    44. Allen AM, McRae-Clark AL, Carlson S, Saladin ME, Gray KM, Wetherington CL, McKee SA, Allen SS. Determining menstrual phase in human biobehavioral research: A review with recommendations. Exp Clin Psychopharmacol. 2016 Feb; 24(1):1-11. PMID: 26570992.
      View in: PubMed
    45. Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, Gray KM, McRae-Clark A, Lofwall MR, Sparenborg S, Walsh SL. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82. PMID: 26708108.
      View in: PubMed
    46. Bentzley JP, Tomko RL, Gray KM. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder. J Subst Abuse Treat. 2016 Apr; 63:72-7. PMID: 26827257.
      View in: PubMed
    47. McRae-Clark AL, Baker NL, Gray KM, Killeen T, Hartwell KJ, Simonian SJ. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75. PMID: 26685701.
      View in: PubMed
    48. McClure E, Baker N, Carpenter MJ, Treiber FA, Gray K. Attitudes and interest in technology-based treatment and the remote monitoring of smoking among adolescents and emerging adults. J Smok Cessat. 2017 Jun; 12(2):88-98. PMID: 28580019.
      View in: PubMed
    49. Froeliger B, McConnell PA, Stankeviciute N, McClure EA, Kalivas PW, Gray KM. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242. PMID: 26454838.
      View in: PubMed
    50. McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37. PMID: 26386827.
      View in: PubMed
    51. Wray JM, Gray KM, McClure EA, Carpenter MJ, Tiffany ST, Saladin ME. Gender differences in responses to cues presented in the natural environment of cigarette smokers. Nicotine Tob Res. 2015 Apr; 17(4):438-42. PMID: 25762753.
      View in: PubMed
    52. Weinberger AH, Smith PH, Allen SS, Cosgrove KP, Saladin ME, Gray KM, Mazure CM, Wetherington CL, McKee SA. Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine Tob Res. 2015 Apr; 17(4):407-21. PMID: 25762750.
      View in: PubMed
    53. Saladin ME, McClure EA, Baker NL, Carpenter MJ, Ramakrishnan V, Hartwell KJ, Gray KM. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy. Nicotine Tob Res. 2015 Apr; 17(4):398-406. PMID: 25762749.
      View in: PubMed
    54. Gray KM, McClure EA, Baker NL, Hartwell KJ, Carpenter MJ, Saladin ME. An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Addiction. 2015 Jun; 110(6):1027-34. PMID: 25727442.
      View in: PubMed
    55. Roten A, Baker NL, Gray KM. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence. Addict Behav. 2015 Jun; 45:119-23. PMID: 25661990.
      View in: PubMed
    56. Kirk HE, Gray K, Riby DM, Cornish KM. Cognitive training as a resolution for early executive function difficulties in children with intellectual disabilities. Res Dev Disabil. 2015 Mar; 38:145-60. PMID: 25561358.
      View in: PubMed
    57. McClure EA, Lydiard JB, Goddard SD, Gray KM. Objective and subjective memory ratings in cannabis-dependent adolescents. Am J Addict. 2015 Jan; 24(1):47-52. PMID: 25823635.
      View in: PubMed
    58. Makary AT, Testa R, Tonge BJ, Einfeld SL, Mohr C, Gray KM. Association between adaptive behaviour and age in adults with Down syndrome without dementia: examining the range and severity of adaptive behaviour problems. J Intellect Disabil Res. 2015 Aug; 59(8):689-702. PMID: 25414060.
      View in: PubMed
    59. Saladin ME, Wray JM, Carpenter MJ, McClure EA, LaRowe SD, Upadhyaya HP, Gray KM. Menstrual cycle phase effects in the gender dimorphic stress cue reactivity of smokers. Nicotine Tob Res. 2015 May; 17(5):607-11. PMID: 25324432.
      View in: PubMed
    60. McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23. PMID: 25179587.
      View in: PubMed
    61. McClure EA, Baker NL, Gipson CD, Carpenter MJ, Roper AP, Froeliger BE, Kalivas PW, Gray KM. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6. PMID: 25062287.
      View in: PubMed
    62. Adisetiyo V, Jensen JH, Tabesh A, Deardorff RL, Fieremans E, Di Martino A, Gray KM, Castellanos FX, Helpern JA. Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment? Radiology. 2014 Aug; 272(2):524-32. PMID: 24937545.
      View in: PubMed
    63. Mathew AR, Wahlquist AE, Garrett-Mayer E, Gray KM, Saladin ME, Carpenter MJ. Affective motives for smoking among early stage smokers. Nicotine Tob Res. 2014 Oct; 16(10):1387-93. PMID: 24924155.
      View in: PubMed
    64. McClure EA, Baker NL, Gray KM. Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. Am J Drug Alcohol Abuse. 2014 Jul; 40(4):285-91. PMID: 24720376.
      View in: PubMed
    65. Jardin BF, Cropsey KL, Wahlquist AE, Gray KM, Silvestri GA, Cummings KM, Carpenter MJ. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014 Jul; 16(7):992-9. PMID: 24610399.
      View in: PubMed
    66. McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM. Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106. PMID: 24442756.
      View in: PubMed
    67. Milsom VA, Malcolm RJ, Johnson GC, Pechon SM, Gray KM, Miller-Kovach K, Rost SL, O'Neil PM. Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71. PMID: 24411753.
      View in: PubMed
    68. Burris JL, Carpenter MJ, Wahlquist AE, Cummings KM, Gray KM. Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial. Nicotine Tob Res. 2014 Apr; 16(4):397-405. PMID: 24130144.
      View in: PubMed
    69. Gray KM. New Developments in Understanding and Treating Adolescent Marijuana Dependence. Adolesc Psychiatry (Hilversum). 2013 Oct 01; 3(4):297-306. PMID: 25289370.
      View in: PubMed
    70. Carpenter MJ, Saladin ME, Larowe SD, McClure EA, Simonian S, Upadhyaya HP, Gray KM. Craving, cue reactivity, and stimulus control among early-stage young smokers: effects of smoking intensity and gender. Nicotine Tob Res. 2014 Feb; 16(2):208-15. PMID: 24042699.
      View in: PubMed
    71. McClure EA, Saladin ME, Baker NL, Carpenter MJ, Gray KM. Smoking topography and abstinence in adult female smokers. Addict Behav. 2013 Dec; 38(12):2833-6. PMID: 24018226.
      View in: PubMed
    72. Gray KM, Piccinin A, Keating CM, Taffe J, Parmenter TR, Hofer S, Einfeld SL, Tonge BJ. Outcomes in young adulthood: are we achieving community participation and inclusion? J Intellect Disabil Res. 2014 Aug; 58(8):734-45. PMID: 23865802.
      View in: PubMed
    73. Thrasher JF, Andrews JO, Friedman DB, Carpenter MJ, Gray KM, Cummings KM, Alberg AJ, Navarro A. Author response. Am J Prev Med. 2013 May; 44(5):e51-3. PMID: 23597825.
      View in: PubMed
    74. Lewis AL, Klintworth EM, Hinton JO, Gray KM. Adolescent Medication Misuse: Results from the MUSC Inventory of Medication Experiences (MIME). Adolesc Psychiatry (Hilversum). 2013 Apr 01; 3(2):184-189. PMID: 24772383.
      View in: PubMed
    75. McClure EA, Gray KM. The Remote Monitoring of Smoking in Adolescents. Adolesc Psychiatry (Hilversum). 2013 Apr 01; 3(2):156-162. PMID: 24834379.
      View in: PubMed
    76. Lewis AL, Baker N, Carpenter M, Klintworth E, Gray KM. Does physician continuity within a clinical trial increase retention and compliance among adolescent smokers? Adolesc Psychiatry (Hilversum). 2013 Apr 01; 3(2). PMID: 24349962.
      View in: PubMed
    77. Saladin ME, Gray KM, McRae-Clark AL, Larowe SD, Yeatts SD, Baker NL, Hartwell KJ, Brady KT. A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans. Psychopharmacology (Berl). 2013 Apr; 226(4):721-37. PMID: 23460266.
      View in: PubMed
    78. Hartwell KJ, Lematty T, McRae-Clark AL, Gray KM, George MS, Brady KT. Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study. Am J Drug Alcohol Abuse. 2013 Mar; 39(2):92-8. PMID: 23421569.
      View in: PubMed
    79. Thrasher JF, Carpenter MJ, Andrews JO, Gray KM, Alberg AJ, Navarro A, Friedman DB, Cummings KM. Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med. 2012 Dec; 43(6):590-600. PMID: 23159254.
      View in: PubMed
    80. Roten AT, Baker NL, Gray KM. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial. Addict Behav. 2013 Mar; 38(3):1788-91. PMID: 23261493.
      View in: PubMed
    81. Gray KM, Carpenter MJ, Baker NL, DeSantis SM, Kryway E, Hartwell KJ, McRae-Clark AL, Brady KT. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12. PMID: 22706327.
      View in: PubMed
    82. Saladin ME, Gray KM, Carpenter MJ, LaRowe SD, DeSantis SM, Upadhyaya HP. Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict. 2012 May-Jun; 21(3):210-20. PMID: 22494223.
      View in: PubMed
    83. Schiller CE, Saladin ME, Gray KM, Hartwell KJ, Carpenter MJ. Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol. 2012 Aug; 20(4):251-7. PMID: 22545725.
      View in: PubMed
    84. Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011 Nov 28; 171(21):1901-7. PMID: 22123796.
      View in: PubMed
    85. Gray KM, Carpenter MJ, Lewis AL, Klintworth EM, Upadhyaya HP. Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. Nicotine Tob Res. 2012 Feb; 14(2):234-9. PMID: 21778151.
      View in: PubMed
    86. Brady KT, Gray KM, Tolliver BK. Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011 Aug; 99(2):285-94. PMID: 21557964.
      View in: PubMed
    87. Gray KM, Riggs PD, Min SJ, Mikulich-Gilbertson SK, Bandyopadhyay D, Winhusen T. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):242-7. PMID: 21411243.
      View in: PubMed
    88. Forster S, Gray KM, Taffe J, Einfeld SL, Tonge BJ. Behavioural and emotional problems in people with severe and profound intellectual disability. J Intellect Disabil Res. 2011 Feb; 55(2):190-8. PMID: 21199050.
      View in: PubMed
    89. Gray KM, Carpenter MJ, Baker NL, Hartwell KJ, Lewis AL, Hiott DW, Deas D, Upadhyaya HP. Bupropion SR and contingency management for adolescent smoking cessation. J Subst Abuse Treat. 2011 Jan; 40(1):77-86. PMID: 20934835.
      View in: PubMed
    90. Gray KM, LaRowe SD, Watson NL, Carpenter MJ. Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. Addict Behav. 2011 Jan-Feb; 36(1-2):140-3. PMID: 20851531.
      View in: PubMed
    91. Gray KM, Baker NL, Carpenter MJ, Lewis AL, Upadhyaya HP. Attention-deficit/hyperactivity disorder confounds nicotine withdrawal self-report in adolescent smokers. Am J Addict. 2010 Jul-Aug; 19(4):325-31. PMID: 20653639.
      View in: PubMed
    92. Carpenter MJ, Baker NL, Gray KM, Upadhyaya HP. Assessment of nicotine dependence among adolescent and young adult smokers: a comparison of measures. Addict Behav. 2010 Nov; 35(11):977-82. PMID: 20624670.
      View in: PubMed
    93. Carpenter MJ, Alberg AJ, Gray KM, Saladin ME. Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers. Clin Trials. 2010 Apr; 7(2):157-66. PMID: 20338901.
      View in: PubMed
    94. Gray KM, Watson NL, Carpenter MJ, Larowe SD. N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict. 2010 Mar-Apr; 19(2):187-9. PMID: 20163391.
      View in: PubMed
    95. Watson NL, Carpenter MJ, Saladin ME, Gray KM, Upadhyaya HP. Evidence for greater cue reactivity among low-dependent vs. high-dependent smokers. Addict Behav. 2010 Jul; 35(7):673-7. PMID: 20206451.
      View in: PubMed
    96. Carpenter MJ, Gray KM. A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: changes in smoking behavior and readiness to quit. Nicotine Tob Res. 2010 Feb; 12(2):136-43. PMID: 20053788.
      View in: PubMed
    97. Gray KM, DeSantis SM, Carpenter MJ, Saladin ME, LaRowe SD, Upadhyaya HP. Menstrual cycle and cue reactivity in women smokers. Nicotine Tob Res. 2010 Feb; 12(2):174-8. PMID: 19996146.
      View in: PubMed
    98. Gray KM, Upadhyaya HP. Tobacco smoking in individuals with attention-deficit hyperactivity disorder: epidemiology and pharmacological approaches to cessation. CNS Drugs. 2009 Aug; 23(8):661-8. PMID: 19594195.
      View in: PubMed
    99. Carpenter MJ, Saladin ME, DeSantis S, Gray KM, LaRowe SD, Upadhyaya HP. Laboratory-based, cue-elicited craving and cue reactivity as predictors of naturally occurring smoking behavior. Addict Behav. 2009 Jun-Jul; 34(6-7):536-41. PMID: 19395178.
      View in: PubMed
    100. Gray KM, Watson NL, Christie DK. Challenges in quantifying marijuana use. Am J Addict. 2009 Mar-Apr; 18(2):178-9. PMID: 19283572.
      View in: PubMed
    101. Gray KM, LaRowe SD, Upadhyaya HP. Cue reactivity in young marijuana smokers: a preliminary investigation. Psychol Addict Behav. 2008 Dec; 22(4):582-6. PMID: 19071985.
      View in: PubMed
    102. Gray KM, Hart CL, Christie DK, Upadhyaya HP. Tolerability and effects of oral Delta9-tetrahydrocannabinol in older adolescents with marijuana use disorders. Pharmacol Biochem Behav. 2008 Nov; 91(1):67-70. PMID: 18627775.
      View in: PubMed
    103. Lydakis C, Momen A, Blaha C, Gugoff S, Gray K, Herr M, Leuenberger UA, Sinoway LI. Changes of central haemodynamic parameters during mental stress and acute bouts of static and dynamic exercise. J Hum Hypertens. 2008 May; 22(5):320-8. PMID: 18273040.
      View in: PubMed
    104. Gray KM, Tonge BJ, Sweeney DJ, Einfeld SL. Screening for autism in young children with developmental delay: an evaluation of the developmental behaviour checklist: early screen. J Autism Dev Disord. 2008 Jul; 38(6):1003-10. PMID: 17972169.
      View in: PubMed
    105. Herring S, Gray K, Taffe J, Tonge B, Sweeney D, Einfeld S. Behaviour and emotional problems in toddlers with pervasive developmental disorders and developmental delay: associations with parental mental health and family functioning. J Intellect Disabil Res. 2006 Dec; 50(Pt 12):874-82. PMID: 17100948.
      View in: PubMed
    106. Gray KM, Upadhyaya HP, Deas D, Brady KT. Advances in diagnosis of adolescent substance abuse. Adolesc Med Clin. 2006 Jun; 17(2):411-25. PMID: 16814700.
      View in: PubMed
    107. Gray KM, Schuyler D. Conquering an Unmasked Social Phobia. Prim Care Companion J Clin Psychiatry. 2003 Jun; 5(3):137-138. PMID: 15154025.
      View in: PubMed
    108. Gray KM, Tonge BJ. Are there early features of autism in infants and preschool children? J Paediatr Child Health. 2001 Jun; 37(3):221-6. PMID: 11468034.
      View in: PubMed
    109. Gray K. Heads up on osteoporosis. J S C Med Assoc. 2001 Feb; 97(2):53-6. PMID: 11235116.
      View in: PubMed
    110. Beischel CJ, Gray K, Hazard ES, Knapp DR, Crouch RK. Evaluation of photoaffinity labeled sites of bacteriorhodopsin using molecular modeling. Biochem Mol Biol Int. 1994 Apr; 32(5):933-9. PMID: 8069243.
      View in: PubMed
    111. Carroll K, Gray K. Memory development: an approach to the mentally impaired elderly in the long-term care setting. Int J Aging Hum Dev. 1981; 13(1):15-35. PMID: 7345028.
      View in: PubMed
    Gray's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _